These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27496924)

  • 21. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of guideline adherence on mortality in treatment of left heart failure].
    Neubauer S; Schilling T; Zeidler J; Lange A; Engel S; Linder R; Verheyen F; von der Schulenburg JG; Haverich A
    Herz; 2016 Nov; 41(7):614-624. PubMed ID: 26883900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circulation; 2010 Aug; 122(6):585-96. PubMed ID: 20660805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2012 Mar; 163(3):430-7, 437.e1-3. PubMed ID: 22424014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF.
    Walsh MN; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Fonarow GC
    J Card Fail; 2010 Dec; 16(12):940-9. PubMed ID: 21111983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex Differences in Patients With Acute Decompensated Heart Failure: Insights From the Heart Function Assessment Registry Trial in Saudi Arabia.
    AlFaleh HF; Thalib L; Kashour T; Hersi A; Mimish L; Elasfar AA; Almasood A; Al Ghamdi S; Ghabashi A; Malik A; Hussein GA; Al-Murayeh M; Abuosa A; Al Habeeb W; Al Habib KF
    Angiology; 2016 Aug; 67(7):647-56. PubMed ID: 26438635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.
    Atwater BD; Dai D; Allen-Lapointe NM; Al-Khatib SM; Zimmer LO; Sanders GD; Peterson ED
    Am Heart J; 2012 Nov; 164(5):750-755.e1. PubMed ID: 23137506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study.
    Lund LH; Carrero JJ; Farahmand B; Henriksson KM; Jonsson Å; Jernberg T; Dahlström U
    Eur J Heart Fail; 2017 Sep; 19(9):1107-1116. PubMed ID: 28229520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure.
    Zsilinszka R; Shrader P; DeVore AD; Hardy NC; Mentz RJ; Pang PS; Peacock WF; Fonarow GC; Hernandez AF
    J Card Fail; 2016 Oct; 22(10):781-8. PubMed ID: 26687985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic tests, treatment and follow-up in heart failure patients--is there a gender bias in the coherence to guidelines?
    Mejhert M; Holmgren J; Wändell P; Persson H; Edner M
    Eur J Heart Fail; 1999 Dec; 1(4):407-10. PubMed ID: 10937955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival.
    Akita K; Kohno T; Kohsaka S; Shiraishi Y; Nagatomo Y; Izumi Y; Goda A; Mizuno A; Sawano M; Inohara T; Fukuda K; Yoshikawa T;
    Int J Cardiol; 2017 May; 235():162-168. PubMed ID: 28259550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-variable risk model in men and women with heart failure.
    Chyu J; Fonarow GC; Tseng CH; Horwich TB
    Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Lam CS; McEntegart M; Claggett B; Liu J; Skali H; Lewis E; Køber L; Rouleau J; Velazquez E; Califf R; McMurray JJ; Pfeffer M; Solomon S
    Eur J Heart Fail; 2015 Mar; 17(3):301-12. PubMed ID: 25655011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure.
    Heidenreich PA; Zhao X; Hernandez AF; Yancy CW; Fonarow GC
    Am Heart J; 2012 Feb; 163(2):239-45.e3. PubMed ID: 22305842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heart failure in men and women: important differences in the diagnostic workup and treatment].
    Lenzen MJ; Rosengren A; Scholte op Reimer WJ; Follath F; Boersma E; M L S; Cleland JG; Komajda M
    Ned Tijdschr Geneeskd; 2008 Oct; 152(40):2182-5. PubMed ID: 18953781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.